Correction: Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: identification of functional disparities between azacytidine and decitabine.

Hsieh, Yao-Yu; Huang, Tsui-Chin; Lo, Hsiang-Ling; Jhan, Jyun-Yan; Chen, Shui-Tein; Yang, Pei-Ming

Hsieh, Yao-Yu; Huang, Tsui-Chin; Lo, Hsiang-Ling; Jhan, Jyun-Yan; Chen, Shui-Tein; Yang, Pei-Ming.

Afiliación

Hsieh YY; PhD Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei, Taiwan.
Huang TC; Division of Hematology and Oncology, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan.
Lo HL; Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Jhan JY; PhD Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei, Taiwan.
Chen ST; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Yang PM; PhD Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei, Taiwan.

Oncotarget ; 9(64): 32402, 2018 08 17.

Article en En | MEDLINE | ID: mdl-30190797

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Aspecto: Equity_inequality Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Taiwán Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google